Key Facts

Invested since 2022
Based in Bavaria

About the company

Ebenbuild is a health tech pioneer that creates personalized treatment recommendations for mechanical ventilation and ICU patient care for clinical users. Founded in Munich in 2019, the company develops software tools that generate precise patient-specific simulation models of lungs based on patient data, so-called digital twins of the lungs. These enable pinpoint individual medical decisions for intensive care patients with acute respiratory distress syndrome (ARDS). In this way, Ebenbuild aims to make a significant contribution to improving treatment as well as reducing mortality.

Do you want to

know more about this company?

Zum Artikel

Tilmann Petersen Investment Manager

Tilmann PetersenInvestment Manager

Ebenbuild in the news

Zum Artikel

News

31. March 2022

Improving ARDS treatment with digital twins: Ebenbuild secures seed financing round led by Bayern Kapital and High-Tech Gründerfonds

More startups from Life Sciences